Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CPIX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.28
 
USD
  
0.01
  
(0.79%)
Previous close: 1.27  Open: 1.24  Bid: 1.2  Ask: 1.47
52 week range    
1.20   
   2.36
Mkt Cap: 19 M  Avg Vol (90 Days): 9,764
Peers   
DRRX / 
IRWD / 
MRK / 
Last updated: Friday 11th October 2024

Stock Rankings

60
Value
44
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

DRRX

0 B-21.285

IRWD

1 B844.21

MRK

0.0281275 B20.04109.4

PFE

0.0575165 B7929.34
Financials

CPIX Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnD760894.0
AcquiredInProcessRnDIncome2 M852102.0
Amortization of intangibles2 M2 M2 M2 M3 M4 M4 M4 M5 M8 M
Basic EPS from continuing operations-0.23-0.65-0.61-0.76-0.44
Basic EPS total0.140.04-0.06-0.5-0.45-0.23-0.44-0.48-0.76-0.44
Basic weighted shares outstanding18 M17 M16 M16 M16 M15 M15 M15 M15 M14 M
BasicDiscontinuousOperations0.210.13
Cost of sales-5 M-5 M-6 M-7 M-6 M7 M9 M9 M9 M6 M
Depreciation unreconciled2 M2 M2 M2 M3 M4 M4 M4 M5 M8 M
DepreciationAndAmortization2 M2 M2 M2 M3 M4 M4 M4 M5 M8 M
Diluted EPS total0.140.04-0.06-0.5-0.45-0.23-0.44-0.48-0.76-0.44
Diluted normalized net income/share-0.23-0.65-0.61-0.76-0.44
Diluted weighted shares outstanding18 M17 M16 M16 M16 M15 M15 M15 M15 M14 M
DilutedDiscontinuousOperations0.210.13
Earnings from equity interest862200.0
EarningsFromEquityInterestNetOfTax862200.0
GainOnSaleOfBusiness1 M
GainOnSaleOfPPE1 M1 M
GainOnSaleOfSecurity2 M1 M
GainsLossOnDisposalOfDiscontinuedOperations6 M3 M2 M
GeneralAndAdministrativeExpense8 M8 M9 M10 M10 M10 M10 M10 M10 M10 M
Gross operating profit34 M29 M27 M34 M33 M27 M29 M27 M33 M33 M
ImpairmentOfCapitalAssets4 M
Income before tax4 M1 M-1 M-4 M-11 M-9 M-7 M-6 M-6 M-6 M
Income restructuring and M&A5 M6 M
Income taxes1 M575829.0-330924.04 M16636.09 M55902.034891.068850.045769.0
InsuranceAndClaims-611330.0-346800.0
Interest income251447.0321531.0204661.0671826.02 M243364.075345.026081.098405.0286854.0
InterestExpenseNonOperating67074.073856.0106392.04 M195848.0246186.0263627.098031.0585995.0667861.0
InterestIncomeOperating622503.0852102.0
MinorityInterests1 M60243.059255.071182.075704.0208752.079496.095212.079798.051446.0
MiscOtherSpecialCharges2 M3 M
Net income from total operations761312.0-4 M-4 M-10 M-8 M-4 M-3 M-4 M-6 M-6 M
NetIncomeCommonStockholders761312.0-4 M-4 M-10 M-8 M-14 M-3 M-4 M-6 M-6 M
NetIncomeContinuousOperations761312.0-4 M-4 M-10 M-8 M-4 M-3 M-4 M-6 M-6 M
NetIncomeDiscontinuousOperations6 M3 M2 M
NetNonOperatingInterestIncomeExpense184373.0247675.098269.0-3 M2 M-2822.0-188282.0-71950.0-487590.0-381007.0
NonRecurringOperationExpense-475000.0
Normalized income-49 M-7 M
Operating income896420.01 M-1 M-4 M-10 M-9 M-6 M-8 M-6 M-10 M
Operating income before depreciation (EBITDA)6 M4 M1 M3 M-8 M-5 M-2 M-857833.0332919.02 M
OperatingExpense33 M27 M29 M38 M44 M36 M35 M35 M38 M43 M
Other income net-2 M5 M3 M-1 M-2 M1 M440091.0-2 M-2 M4 M
Other special charges4 M
OtherGainLossFromDispositionOfDiscontinuedOperations6 M3 M2 M
OtherGandA8 M8 M9 M10 M10 M10 M10 M10 M10 M10 M
OtherOperatingExpenses-621142.0-618756.0613637.01 M1 M1 M1 M
OtherTaxes4 M3 M
OtherWriteDown3 M440091.0
OtherWriteOff5 M3 M
PromotionAndAdvertising-2 M-3 M-3 M-3 M-2 M3 M2 M2 M3 M3 M
RentAndLandingFees8 M8 M9 M10 M10 M-688020.0-680627.0
Research & development expense3 M4 M3 M4 M8 M7 M6 M6 M7 M6 M
ResearchExpense3 M4 M3 M4 M8 M7 M6 M6 M7 M6 M
RestructringAndMnAIncome5 M6 M
Revenue per share2 M2 M2 M2 M3 M4 M4 M4 M5 M8 M
SalariesAndWages-761663.03 M
SecuritiesAmortization2 M
Selling Gen & administrative expense23 M22 M23 M32 M30 M25 M25 M25 M26 M29 M
SellingAndMarketingExpense15 M14 M15 M21 M20 M15 M15 M15 M17 M18 M
SellingExpense15 M14 M15 M21 M20 M
Special income/charges-4 M-4 M-5 M-6 M475000.0
Total Income available for interest expense (EBIT)4 M1 M-1 M-62132.0-11 M-9 M-6 M-5 M-5 M-6 M
Total common shares outstanding17 M16 M16 M16 M15 M15 M15 M15 M14 M14 M
Total net income761312.0-4 M-4 M-10 M-8 M-4 M-3 M-4 M-6 M-6 M
Total ordinary shares14 M14 M14 M14 M14 M14 M14 M14 M14 M14 M
Total revenues39 M34 M33 M41 M41 M34 M37 M36 M42 M40 M
TotalExpenses28 M22 M23 M30 M38 M44 M44 M44 M47 M49 M
TotalRevenue37 M33 M32 M41 M41 M34 M37 M36 M42 M40 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University